The use of genomics is expanding in the medical industry, which is creating growth opportunities for the Global Genomics Market. Fortune Business Insights in a new report, titled “Genomics: Global Market Analysis, Insights and Forecast, 2019-2026” offers valuable insights into the factors enabling growth in the market.

Genomics Market is most commonly used for the diagnosis of cancer. Recent advancements in personalized medicine and genomics have bought significant transformations in disease management. The growing use of genomics in several clinical trials is reflecting a growing trend. Consequently, The Global Genomics Market is expected to rise at an exponential CAGR of 18.7% between 2018 and 2026. In 2018, the market was valued at US$ 15,888.8 Mn and it is anticipated to reach US$ 62,614.6 Mn by 2026.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/genomics-market-100941

Key Players Operating in The Genomics Market Include:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

• Thermo Fisher Scientific Inc.
• Oxford Nanopore Technologies
• Danaher
• QIAGEN
• BGI
• IntegraGen

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/genomics-market-100941

Adoption of Advanced Technologies Renders North America Dominant

From a geographical standpoint, North America dominated the global genomics market in 2018. The region will continue to maintain its dominance through the forecast period. Rapid technological advancements and the presence of sophisticated healthcare infrastructure are driving the market in this region. In 2018, North America was valued at US$ 6,959.3 Mn. The demand for genomic medicine is increasing in North America on account of the rising adoption of personalized medicine and new sequencing technologies.

Europe is expected to display great growth potential owing to the wide availability of funds and the presence of large MNCs. Governments in the U.K. is increasingly making investments in research and development (R&D) activities to favour the expansion of the market in Europe.

The market in Asia Pacific is likely to witness strong growth during the forecast years. The primary factor responsible for the growth is developing healthcare infrastructure. The awareness about genomic technologies is increasing in countries such as India and China, as people in these countries are becoming more aware with regards to the detection of genetic disorders, their treatment and prognosis. All these factors are enabling growth in the market.

Start-ups to Focus on Providing Genomics Services to Customers

Veritas Genomics announced the launch of new genome sequencing products in November 2018. The company aims to enhance its customer service and expand its product portfolio. Other companies such as Agilent Technologies, Inc., Illumina, Inc., and F. Hoffmann-La Roche Ltd are expected to lead the market in the forecast period. This is mainly on account of their strong product portfolio and wide geographical reach. Among these companies, Illumina acquired a leading position in 2018 owing to the acquisition of Pacific Biosciences.

The global compression therapy market size is projected to reach USD 4.51 billion by 2026, exhibiting a CAGR of 5.2% during the forecast period. Rising prevalence of cancer will be a key growth driver for this market in the coming decade, finds Fortune Business Insights™ in its report, titled “Compression Therapy Market Size, Share and Industry Analysis By Product (Compression Garments {Compression Bandages, Compression Stockings, and Others}, Compression Pumps, and Others), By Application (Venous Leg Ulcer, Deep Vein Thrombosis (DVT), Lymphedema, and Others), By End User (Hospitals & Clinics, Nursing Care Centers, Home Care, and Others), and Regional Forecast, 2019-2026”. The global disease burden of cancer, according to the International Agency for Research on Cancer (IARC), rose by an estimated 18.1 million new cases in 2018.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/albumin-market-102637

List of Top Players Covered in the Report:

• Tactile Systems Technology, Inc.
• Smith & Nephew
• medi GmbH & Co. KG
• Arjo
• SIGVARIS
• Bio Compression Systems, Inc.
• EssityAktiebolag (publ)
• PAUL HARTMANN Pty. Ltd
• 3M

The compression therapy market report states that the value of the market was at USD 3.01 billion in 2018. Other highlights of the report include:

• Precise computation of market figures and values;
• Elaborative overview of the overall industry outlook;
• Exhaustive analysis of the key market drivers, trends, and restraints;
• Detailed segmentation of the market and comprehensive study of all segments; and
• In-depth research into the regional milieu and competitive developments in the market.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/albumin-market-102637

Market Driver

Increasing Geriatric Population to Stoke Growth

The world population is aging at an astonishing rate. Demographic analysis of the UN Department of Economic and Social Affairs (DESA) suggests that by 2050, the number of people aged 60 years and above is set to double, reaching 2.1 billion. Aging entails a host of health problems and vein disorders are some of the most common ailments that inflict older people. For example, old age is a high risk factor for varicose veins as the wear & tear of valves in the veins causes the blood to flow back into the veins instead flowing towards the heart. Similarly, the incidence of deep vein thrombosis is high among the geriatric population due to reduced physical movement. Thus, expanding aging population worldwide is expected to be a major demand-puller for compression therapies, thereby augmenting the compression treatment market growth.

TOC Followed:

1. Introduction
   • Research Scope
   • Market Segmentation
   • Research Methodology
   • Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
   • Market Drivers
   • Market Restraints
   • Market Opportunities
4. Key Insights
   • Prevalence of Venous Leg Ulcer, DVT, Lymphedema and other key indications by country/region
   • Key Industry Trends
   • Key Industry Developments (Mergers, Acquisitions, and Partnerships)
   • New Product Launches
5. Global Compression Therapy Market Analysis, Insights and Forecast, 2015-2026
   • Key Findings / Summary
   • Market Analysis, Insights and Forecast – By Product
     • Compression Garments
       • Compression Bandages
       • Compression Stockings
       • Others
     • Compression Pumps
     • Others

TOC Continued..

The global albumin market is likely to gain traction from the rising usage of recombinant DNA technology to safely produce significant proteins and other components in the laboratory setting. This information is given by Fortune Business Insights™ in a recent study, titled, “Albumin Market Size, Share & Industry Analysis, By Product (Human Serum Albumin (HSA), Recombinant Albumin, and Bovine Serum Albumin (BSA)), By Application (Therapeutics, Diagnostics, and Research) By End User (Hospital & Clinics, Pharmaceutical & Biotechnology Industry, and Research Institutes), and Regional Forecast, 2019-2026.” The study further states that the albumin market size was USD 4.29 billion in 2018 and is projected to reach USD 6.77 billion by 2026, exhibiting a CAGR of 6.0% during the forecast period.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/albumin-market-102637

Fortune Business Insights™ lists out some of the most prominent companies operating in the albumin market. They are as follows:

• Kedrion S.p.A
• Octapharma AG
• Biotest AG
• Takeda Pharmaceutical Company Limited
• CSL Limited
• Merck KGaA
• Grifols, S.A
• Seracare Life Sciences
• Novozymes
• Other prominent players

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/albumin-market-102637

What Does This Report Contain?

• In-depth information about albumin market trends, growth drivers, and barriers.
• Competitive landscape including mergers and acquisitions, collaborations and partnerships, innovative product launches, investments, agreements, and contracts.
• Extensive analysis of the dominant region present in the market.
• Profiles of all the renowned organizations and the strategies that they are following to generate more sales.
• List of all the segments.

Drivers & Restraints-

Development of Fractionation Facilities to Skyrocket Demand

Usage of protein is upsurging day by day owing to their possession of several advantages. They are mainly used in the development of crucial drugs. Italy, the U.S., and Belgium, for instance, are exhibiting high demand for protein. It is, in turn, leading to the construction of multiple fractionation facilities for keeping up with the demand and supply balance. These facilities help in fragmenting plasma into albumin and other components. Development of such facilities is aiding the biotechnology and pharmaceutical industries in creating state-of-the-art products for research, diagnostics, and therapeutics applications. However, unavailability of therapeutic products may hinder market growth.

Segment-

Therapeutic Segment to Dominate Owing to Rising Prevalence of Hypovolemia

Based on application, the market is grouped into diagnostics, research, and therapeutics. Amongst these, the therapeutics segment held 66.4% albumin market share in 2018. This segment is likely to remain in the dominant position throughout the forecast period stoked by the increasing prevalence of hypovolemia and other similar disorders. Therefore, the sales of drugs for treating these disorders are also rising. Companies, such as CSL Limited and Takeda are the major contributors to growth of this segment by developing innovative plasma-derived products. Several pharmaceutical, as well as biotechnology companies are also investing huge sums in research and development activities to unveil new therapeutic products.

The global wound closure market is set to gain impetus from the ever-increasing inclination of people from traditional suturing techniques to innovative devices, namely, hemostatic agents, clips, and staplers. It is mainly occurring in countries such as India, China, Japan, Germany, and the U.S. Fortune Business Insights™ provided this information in a recent report, titled, “Wound Closure Market Size, Share & Industry Analysis, By Product Type (Sutures, Hemostatic Agents, Staplers, Staples, and Others), By Application (Gynaecology, Cardiology, Orthopedics, Ophthalmic, General Surgery, and Others), By End User (Hospitals and Ambulatory Surgical Centers, Specialty Clinics, and Others), and Regional Forecast, 2019-2026.” The report further mentions that the wound closure market size was USD 13.24 billion in 2018 and is projected to reach USD 21.03 billion by 2026, exhibiting a CAGR of 6.0% during the forecast period.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/wound-closure-market-102630

Fortune Business Insights™ lists out all the companies that are presently operating in the wound closure market. They are as follows:

• Cryolife
• Baxter
• Johnson and Johnson Service, Inc.
• Smith & Nephew
• Stryker
• Medtronic
• Braun Melsungen AG
• CP Medical
• 3M

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/wound-closure-market-102630

This Report Answers the Following Questions:

• How many growth drivers and hindrance would the market come across in the near future?
• What are the most significant wound care market trends, challenges, and opportunities?
• How many companies are set to lead the market in terms of maximum revenue?
• Which region is likely to dominate the market in the coming years?
• What are the vital strategies adopted by key players to boost sales?

Drivers & Restraints-

High Demand for Minimally Invasive Wound Closure Devices to Boost Growth

Since the past few years, the market is exhibiting tremendous technological advancements. They are mainly focused on lower incidence of hospital-acquired infection, reduced price, ease-of-use, and lesser healing time of the incision. Reputed companies are trying to bring about all these features in their products to gain more share. Besides, consumers are nowadays seeking out for minimally invasive devices so that they would reduce a healthcare professional’s time that is usually spent in the ER room, as well as the time for post-operative care. These factors are likely to accelerate the wound closure market growth during the forecast period. However, the rising number of product recalls may obstruct market growth.

The global cosmetic surgery market is likely to gain traction from the ever-increasing number of patients undergoing procedures, such as chin augmentation, breast reduction, and breast augmentation. The American Society for Aesthetic Plastic Surgery (ASAPS) declared that in 2018, breast reduction (18%) and chin augmentation (20%) were two of the most popular surgical procedures in the U.S. This information is given by Fortune Business Insights™ in a recent report, titled, “Cosmetic Surgery Market Size, Share & Industry Analysis, By Type (Surgical Procedures, and Non-Surgical Procedures), By Gender (Males, and Females), By End User (Spas & Cosmetic Surgery Centers, and Hospitals & Specialty Clinics), and Regional Forecast, 2019-2026.” The report further states that the cosmetic surgery market size was USD 50.67 billion in 2018 and is projected to reach USD 66.96 billion by 2026, exhibiting a CAGR of 3.6% during the forecast period.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/cosmetic-surgery-market-102628

Fortune Business Insights™ lists out some of the most reputed companies present in the aesthetic surgery market. They are as follows:

• TETIK
• Westlake Dermatology
• Long Island Plastic Surgical Group, P.C.
• ALLERGAN
• Merz Pharma
• Galderma Laboratories
• Cleveland Clinic
• Other key market players

What Does This Report Contain?

• Elaborate information about the factors that would accelerate the market growth in the coming years.
• Comprehensive data about all those factors that are set to pose as growth barriers.
• In-depth analysis of the cosmetic surgery market trends, challenges, and opportunities.
• A thorough analysis of the competitive landscape and profiles of all the vendors.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/cosmetic-surgery-market-102628

Drivers & Restraints-

Rising Emphasis on Reduced Post-surgical Interventions to Propel Growth

The market consists of several prominent companies that are presently focusing on capitalizing their market share by delivering new instruments and products to the masses. Besides, the demand for unique products with reduced post-surgical interventions and adverse effects is aiding these companies in investing huge sums in research and development activities.

Furthermore, patients and healthcare providers are nowadays looking for state-of-the-art products. Coupled with this, the rising emphasis on removing the harmful effects of implants and other similar cosmetic procedures would contribute to the aesthetic surgery market growth in the near future. However, the emergence of non-licensed facilities worldwide may hamper the market growth.

TOC Content:

1. Introduction

1.1.      Research Scope

1.2.      Market Segmentation

1.3.      Research Methodology

1.4.      Definitions and Assumptions

2. Executive Summary
3. Market Dynamics

3.1.      Market Drivers

3.2.      Market Restraints

3.3.      Market Opportunities

4. Key Insights

4.1.      Statistics: Key Procedures, By Key Countries, 2018

4.2.      Pricing Analysis, Key Procedures, By Key Countries, 2018

4.3.      Technology Advances, Cosmetic Procedures

4.4.      Recent Developments, Key Mergers/ Acquisitions, New Product Launches, etc.

TOC Continued…

The global microfluidic devices market is expected to gain impetus from increasing technological advancements in the biotechnology domain. According to a report by Fortune Business Insights, titled, “Microfluidic Devices Market Size, Share & Industry Analysis, By Device Type (Chips, Sensors, and Others), By Material (Glass, Silicon, PDMS and Others), By Applications (Pharmaceutical & Life Science Research, Diagnosis & Treatment, and Others), By End-user (Diagnostic Centers, Research Institutes, Pharmaceutical and Biotechnology Companies, Healthcare Facilities and Others) and Regional Forecast, 2019-2026,” the market is projected to reach USD 22.65 Billion by 2026, thereby exhibiting a CAGR of 20.5% during the forecast period. However, the global microfluidic devices market size was valued at USD 5.14 Billion in 2018. The report further states that renowned market players are focusing on low-cost materials for manufacturing microfluidic sensors and chips. It would contribute to the market growth in the forthcoming years.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/microfluidic-devices-market-101098

Fortune Business Insights profiles some of the renowned companies operating in the global microfluidic devices market. They are as follows:

• uFluidix
• Perkin Elmer
• Fluidigm
• Blacktrace Holdings Ltd. (Dolomite Microfluidic)
• Micronit
• BioFluidix GmbH‎
• Fluigent
• ALine, Inc.
• Philips

The report consists of the latest releases and new mechanical enhancements to engage the consumers to settle on instructed business decisions, design, and complete their required executions. It mainly focuses on the microfluidic devices market trends, open entryways, upcoming changes in methodology, and current business and progressions.

Request a Sample Copy of the Global Microfluidic Devices Market Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/microfluidic-devices-market-101098

Highlights of the Report

• In-depth analysis of various insights, namely, Microfluidic Devices Market trends, growth drivers, opportunities, and other related challenges.
• Comprehensive details of key market players, their core competencies, and market shares.
• The potency of suppliers and buyers to make better business decisions.
• Lists out the market size in terms of volume.

Rising Usage of Microfluidic Devices to Boost Growth of Pharmaceutical and Biotechnology Companies Segment

In terms of end-user, the global microfluidic devices market is grouped into pharmaceutical and biotechnology companies, research institutes, diagnostic centers, and healthcare facilities and others. Out of these, the pharmaceutical and biotechnology companies segment is projected to lead the global market by acquiring the highest revenue in terms of share. It would occur due to the increasing manufacturing and usage of sensors, chips, and other microfluidic devices to offer novel and robust devices to the consumers. However, diagnostic centers and research institutes will also grow rapidly during the forecast period by utilizing microfluidic devices for various applications.

The global pet insurance market size is projected to reach USD 11.25 billion by 2026. The increasing pet adoption in leading countries across the world will have a direct impact on the growth of the market. According to a report published by Fortune Business Insights, titled “Pet Insurance Market Size, Share & Industry Analysis, By Policy Coverage Type (Accident & Illness, Accident Only, Others), By Animal Type (Dog, Cat, Others), By Provider (Public, Private) and Regional Forecast, 2019-2026,” the market was worth USD 6.05 billion in 2018. Driven by flexibility in product offerings, the market will exhibit a CAGR of 8.0% during the forecast period, 2019-2026.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/pet-insurance-market-101956

A few of the leading companies that are operating in the global market include:

• Trupanion
• Anicom Holdings
• Nationwide Mutual Insurance Company
• ASPCA
• Healthy Paws Pet Insurance, LLC.
• Embrace Pet Insurance Agency, LLC
• Figo Pet Insurance LLC.
• Agria Pet Insurance Ltd
• 24PetWatch
• Pets Best Insurance Services, LLxC.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/pet-insurance-market-101956

The pet insurance market will benefit from the increasing pet adoption in leading countries across the world. Pet insurance refers to a policy that covers medical as well as accidental factors that is associated with the pets. The emphasis on the well-being and health of pets, by private as well as government organizations will create several growth opportunities. The presence of several private organizations offering premium insurance policies will have a positive impact on the growth of the market in the forthcoming years. Several companies are focused on offering novel services as well as concessions in a bid to establishing a stronghold in the market. These factors will aid the growth of the market in the coming years.

Europe to Emerge Dominant; Influx of Start-ups to Aid Growth

The report analyzes the ongoing pet insurance market trends across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Among these regions, the market in Europe generated the highest market revenue in 2018. Europe is projected to dominate the market in the coming years driven by the increasing number of start-ups in several countries across this region. The increasing number of government initiatives to promote animal wellness and health, coupled with encouragement for pet adoption, will aid the growth of the market in this region. Besides Europe, the market in North America will exhibit considerable CAGR. As of 2018, the market in North America was worth USD 1.42 billion and this value is likely to increase further in the coming years.

Detailed Table of Content:

1. Introduction
   • Research Scope
   • Market Segmentation
   • Research Methodology
   • Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
   • Market Drivers
   • Market Restraints
   • Market Opportunities
4. Key Insights
   • Pricing Analysis of Top Insurers, by Animal Type
   • Pet Adoption Statistics, Across Major Countries
   • Key Merger And Acquisition Strategies by Top Players
   • New Product Launch
5. Global Pet Insurance Market Analysis, Insights and Forecast, 2015-2026
   • Key Findings / Summary
   • Market Analysis, Insights and Forecast – By Policy Coverage Type
     • Accident & Illness
     • Accident Only
     • Others
   • Market Analysis, Insights and Forecast – By Animal Type
     • Cat
     • Dog
     • Others

TOC Continued..

The global prefilled syringes market size is projected to reach USD 9.53 billion by 2026, exhibiting a CAGR of 10.4% during the forecast period. Rising incidence of cancer and other Non-Communicable Diseases (NCDs) is expected to be the primary factor fueling the prefilled syringe market growth. According to the World Health Organization (WHO), 9 million deaths are caused by cancer worldwide every year. In total, NCDs cause close to 41 million deaths, or 71% of the global deaths, annually, states the WHO. The National Cancer Institute estimates that in the US alone, 1,735,530 new cancer cases were reported in 2018; by 2030, this figure is anticipated to reach 23.6 million. Such widespread prevalence of cancer and other NCDs has generated the need for alternative solutions such as biological drugs. The administration of these drugs requires modern devices such as prefilled syringes, which is foreseen to augment the prefilled syringes market potential in the forthcoming years.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/prefilled-syringes-market-101946

Top Players Identified in the Prefilled Syringe Market Report:

• BD
• Gerresheimer AG
• AptarGroup, Inc.
• Helvoet Rubber & Plastic Technologies BV
• West Pharmaceutical Services Inc.
• SCHOTT AG
• Terumo Corporation
• Nipro PharmaPackaging International
• Other Prominent Players

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/prefilled-syringes-market-101946

Fortune Business Insights™ provides the above information in its new report, titled “Prefilled Syringes Market Size, Share & Industry Analysis, By Material (Glass and Plastic) By Closing System (Staked Needle System, Luer Cone System, and Luer Lock Form System) By Product (Complete Syringe Set and Components & Accessories) By Design (Double-chamber, Multiple-chamber, and Single-chamber) By End-user (Pharmaceutical & Biotechnology Companies, Contract Research & Manufacturing Organizations, and Others) and Regional Forecast, 2019-2026”. The report states that the value of this market stood at USD 4.31 billion in 2018 and also shares the following information:

• Detailed assessment of the drivers and factors influencing the market;
• In-depth analysis of the restraints holding back the development of the market;
• Careful research into the various market segments; and
• Comprehensive evaluation of the regional and competitive landscape of the market.

Rising Instances of Opportunistic Infections and Injuries at Hospitals to Boost the Market

Infections and injuries caused by needle sticks can be hazardous as they can cause serious damage to the body. According to the National Institute for Occupational Safety and Health (NIOSH), USA, a needle stick injury is one that is caused by sharp and pointed objects such as blood collection and hypodermic needles. Increasing workload of healthcare professionals at medical facilities such as hospitals has upped the threat of opportunistic injuries for these people, thereby expanding the prefilled syringes market size. For example, the US Centers for Disease Control and Prevention (CDC) numbered the injuries caused by sharp objects in US hospitals at 600,000. Thus, as patient care gets more complex and demanding, safety concerns regarding needle stick injuries are expected to gain prominence and lead the prefilled syringes market trends in the upcoming years.

Detailed Table of Content:

1. Introduction
   • Research Scope
   • Market Segmentation
   • Research Methodology
   • Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
   • Market Drivers
   • Market Restraints
   • Market Opportunities
4. Key Insights
   • Regulatory Scenario by Key Countries/Key Region
   • Overview of Secondary Prefilled Containers such as Auto-injectors, Pens, etc.
   • Prefilled Syringes Key Market Trends
   • Overview of Contract Research and Manufacturing Service Providers for Prefilled Syringes
   • Key Industry Developments (Mergers, Acquisitions, Strategic Partnerships, Collaborations, etc.)

The global spinal fusion devices market is projected to reach USD 8.45 billion by 2026, exhibiting a CAGR of 3.6% during the forecast period. A rapidly rising global geriatric population will be a critical factor driving the growth of this market. According to the United Nations, around 16% of the world’s population will be over the age of 65 by 2050. In North America and Europe, close to 25% of the population will be aged. Aged people are highly vulnerable to various kinds of injuries and spinal cord injuries are one of the most common afflictions of old age. For instance, a study published in the Lancet journal showed that in the US, the average age of patients who suffered from spinal cord damage rose from 40 years to 50 years in just two decades. This shows that as geriatric population increases, the risk of spinal cord injuries also rises in tandem, thereby spiking the demand for spinal arthrodesis devices in the long-run.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/spinal-fusion-devices-market-101689

Fortune Business Insights identifies some of the prominent competitors in this market:

• DePuy Synthes (Johnson & Johnson Services, Inc.)
• Aesculap, Inc. (B. Braun Melsungen AG)
• Stryker
• Alphatec Spine, Inc.
• RTI Surgical Holdings, Inc.
• Zimmer Biomet
• Medtronic
• NuVasive, Inc.

Request a Sample Copy of the Global Spinal Fusion Devices Market Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/spinal-fusion-devices-market-101689

According to a new report published by Fortune Business Insights, titled “Spinal Fusion Devices Market Size, Share & Industry Analysis, By Product Type (Cervical Devices, Thoracolumbar Devices, Interbody Devices, and Biologics), By Disease Indication (Degenerative Disc Disease, Complex Deformity, Traumas & Fractures, and Others), By End User (Hospitals & Ambulatory Surgery Centers, Specialty Clinics and Others) and Regional Forecast, 2019-2026”, the market value stood at USD 6.37 billion in 2018. Within the report is also contained an exhaustive evaluation and analysis of the drivers, restraints, and other dynamics that will influence the market in the forecast period. Besides this, the report also provides a macroscopic overview of the general industry trends that will enable businesses to align their strategies with the needs of the market.

A spinal fusion device or implant is an orthopedic surgical mechanism which is used to join or keep in place two or more vertebrae. They consist of interbody devices, biologics, cervical fixation devices, and thoracolumbar fixation devices.

Growing Adoption of Surgical Robots for Spinal Injuries to Prove Favorable for the Market

There is an increasing demand for minimally invasive surgical procedures, prompting many hospitals to adopt robots for performing surgical procedures for the spinal treatments. As a result, manufacturers are now increasingly engaging in developing novel robotic technologies to aid surgeons perform tricky spinal cord surgeries with greater ease and accuracy. Thus, emergence of robotics in healthcare is, therefore, expected to shape the spinal fusion devices market trends during the forecast period.

Some major points from Table of Content:

1. Introduction
   • Research Scope
   • Market Segmentation
   • Research Methodology
   • Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
   • Market Drivers
   • Market Restraints
   • Market Opportunities
4. Key Insights
   • Prevalence of Key Spinal Diseases – For Key Countries/Regions
   • Regulatory Scenario – For Key Countries/Regions
   • Reimbursement Scenario – For Key Countries/Regions
   • New Product Launches
   • Key industry Developments – Mergers, Acquisitions and Partnerships
   • Key Industry Trends

TOC Continued…

The global drug eluting stents (DES) market size is forecast to reach USD 8.98 billion by 2026, attributable to the increasing prevalence of cardiovascular diseases worldwide. A drug eluting stent is a semi-rigid device in the form of a tube that is coated with a drug that helps to prevent reoccurrence or restenosis of an arterial blockage when released. They help to reduce restenosis cases and also limits the risk of late or early thrombosis in patients. More information on the market is provided in a recently published report by Fortune Business Insights™ titled, “Drug Eluting Stents (DES) Market Size, Share & Industry Analysis, By Type (Coronary Stenting, and Peripheral Stenting), By Product (Polymer-based, and Polymer-free), By Scaffold (Cobalt-Chromium, Platinum-Chromium, Nitinol and Others), By Drug (Sirolimus, Paclitaxel, Zotarolimus, Everolimus, and Others), By End User (Hospitals, and Specialty Clinics), and Regional Forecast, 2019-2026.” As per this report, the market value was USD 5.71 billion in 2019 and will exhibit a CAGR of 6.7% between 2019 to 2026.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/drug-eluting-stent-des-market-102612

List of Significant Drug Eluting Stents (DES) Market Manufacturers are as follows:

• Abbott
• Boston Scientific Corporation
• Biotronik
• MicroPort Scientific Corporation
• Medtronic
• Terumo Corporation
• Other Players

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/drug-eluting-stent-des-market-102612

What is the Scope of the Report?

The report offers a 360-degree overview of the market and its prime growth trajectories such as drivers, restraints, challenges, and upcoming opportunities. It also discusses the market segment based on factors such as type, scaffold, drug, end-user, and regions. It also provides market figures and CAGRs of the leading segments wit its attributed reasons. Additionally, the report throws light on current drug eluting stents market trends, key industry developments, and other interesting insights. Competitive landscape, list of players operating in the market and the strategies adopted by them to earn the leading position in the market are also listed in the report. For more information on the report, log on to the company website.

Market Drivers

Improving Healthcare Infrastructure in developing nations will Propel Growth

The increasing cases of cardiovascular diseases worldwide are a significant factor in boosting the global market for drug eluting stents. Besides this, government-supported reimbursement policies and a rise in expenditure on research and development of better stents are also aiding in the expansion of the market. This, coupled with the FDA approvals and CE marks received by many stents, is expected to promote the drug eluting stents market growth in the forecast period.

Table of Content

1. Introduction

1.1.      Research Scope

1.2.      Market Segmentation

1.3.      Research Methodology

1.4.      Definitions and Assumptions

2. Executive Summary
3. Market Dynamics

3.1.      Market Drivers

3.2.      Market Restraints

3.3.      Market Opportunities

4. Key Insights

4.1.      Prevalence of Cardiovascular Diseases, By Key Regions/ Key Countries, 2018

4.2.      New Product Launches, By Key Market Players

4.3.      Key Industry Developments, Such as Mergers & Acquisition

TOC Continued…